Church of PeptidesSearch
Portrait of Secretin
Prophets · 1902

Secretin

The First Whisper

London, England

Secretin is an intestinal hormone that prompts the pancreas to release bicarbonate-rich fluid. Its place in this canon reflects a fundamental idea: one organ can send a chemical message to another through the blood. Clinical secretin testing uses that response for specific diagnostic questions.

Evidence ladder: Approved human useFoundational biology · human evidence variesEducational record
ClassificationProphets
Evidence summaryFoundational biology · human evidence varies
OriginLondon, England
Scientific record

What the evidence says

Established role or proposed benefit

  • Established the concept that organs communicate through chemical messengers.
  • Coordinates pancreatic bicarbonate release after acid enters the small intestine.

Side effects, risks, and limits

  • Not a general digestive tonic.
  • Modern use is narrow and clinical rather than a wellness shortcut.
Doctide’s verdict

The First Whisper helped explain how organs communicate. Its clinical value is in asking a precise diagnostic question under controlled conditions, not in promising to improve digestion whenever the pancreas answers.

Documented history

Where the real story begins

Bayliss and Starling published The mechanism of pancreatic secretion in 1902. Their work became a foundational record in the study of chemical communication between the intestine and pancreas. The historical discovery and later diagnostic preparations are separate chapters in secretin’s story.

London, England · 1902
Book of the Canon · comic scripture

The laboratory legend

Secretin knocked once on the pancreas and received a river of bicarbonate. Doctide called it impossible until the intestine produced the receipt.

This bold passage is invented comedy, not scientific or historical fact.
Editorial recordProfile editorial revision: October 4, 2026Prepared under the Church of Peptides evidence standardEditorial review: Church of PeptidesIndependent clinical review: none to dateContent evidence reviewed: September 12, 2026
Evidence ledger

Sources

Source links checked: October 4, 2026. The historical physiology experiment documents discovery, not modern prescribing indications.

  1. Bayliss and Starling: The mechanism of pancreatic secretion, 1902
  2. FDA Drugs@FDA database
  3. FDA: historical SecreFlo diagnostic label, 2002

Fiction disclosure: The bold laboratory legend is invented. The historical and scientific sections are factual summaries; no invented connective events were added.

Educational entertainment only. Not medical advice, diagnosis, dosing guidance, or a recommendation to obtain or use a product.